Steroid- and immunosuppressive-resistant nephrotic syndrome in focal and segmental glomerulosclerosis and hyalinosis (FSGSH) with progressive chronic kidney disease: diagnostic and therapeutic challenges

This report presents a complex case of an 18-year-old patient with multiresistant nephrotic syndrome secondary to focal and segmental glomerulosclerosis and hyalinosis (FSGSH), characterized by massive proteinuria (47 to 11 g/24 h), severe hypoproteinemia (albumin 6–17 g/L), immunologic abnormalities (C3, IgM, and C1q deposits), dysregulation of the alternative complement pathway, and a lack of response to standard, combined, and biological therapies. The clinical course included a progressive decline in eGFR, development of anemia, hypercoagulability, infectious complications, and the need for ultrafiltration and hemodialysis. This case reflects the therapeutic limitations in FSGSH and highlights the need for personalized, pathophysiology-based treatment strategies.

Authors

Institutions

Publication Details

Journal
Pharmacia
Published
2026-01-20
DOI
https://doi.org/10.3897/pharmacia.73.e182594
Primary Topic
Renal Diseases and Glomerulopathies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Steroid- and immunosuppressive-resistant nephrotic syndrome in focal and segmental glomerulosclerosis and hyalinosis (FSGSH) with progressive chronic kidney disease: diagnostic and therapeutic challenges

L.G. Kitova, D. Nikolov, Maria-Florance Kitova, Anna A. Mihaylova et al.
Pharmacia
Renal Diseases and Glomerulopathies
article

Steroid- and immunosuppressive-resistant nephrotic syndrome in focal and segmental glomerulosclerosis and hyalinosis (FSGSH) with progressive chronic kidney disease: diagnostic and therapeutic challenges

L.G. Kitova, D. Nikolov, Maria-Florance Kitova, Anna A. Mihaylova, George Nikolov, Spas Kitov
article en

Abstract

This report presents a complex case of an 18-year-old patient with multiresistant nephrotic syndrome secondary to focal and segmental glomerulosclerosis and hyalinosis (FSGSH), characterized by massive proteinuria (47 to 11 g/24 h), severe hypoproteinemia (albumin 6–17 g/L), immunologic abnormalities (C3, IgM, and C1q deposits), dysregulation of the alternative complement pathway, and a lack of response to standard, combined, and biological therapies. The clinical course included a progressive decline in eGFR, development of anemia, hypercoagulability, infectious complications, and the need for ultrafiltration and hemodialysis. This case reflects the therapeutic limitations in FSGSH and highlights the need for personalized, pathophysiology-based treatment strategies.

PharmaciaVol. 73
Medical University Plovdiv (BG)
Good health and well-being
Openalex Percentile: Top 85%
Renal Diseases and Glomerulopathies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.